ROP Financial Statements & Analysis
Complete financial statements for ROP including income statement, balance sheet, and cash flow statement. Analyze ROP's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
58
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
13.9% ↑
Net Income
13.6% ↑
Gross Margin
-0.6% ↓
Operating Margin
0.4% ↑
Balance Sheet
Current Ratio
-19.5% ↓
Debt to Equity
11.3% ↓
Asset Turnover
2.4% ↑
Cash Flow
Operating Cash Flow
17.6% ↑
Net Cash Flow
95.5% ↑
Free Cash Flow
20.8% ↑
Cash Flow to Debt
-2.3% ↓
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 6.18B | 7.04B | 13.9% | |
| Gross Profit | 4.31B | 4.88B | 13.3% | |
| Operating Income | 1.75B | 2.00B | 14.4% | |
| Net Income | 1.36B | 1.55B | 13.6% | |
| EPS | 12.7983 | 14.4659 | 13.0% | |
| EBITDA | 2.66B | 3.04B | 14.1% | |
| Gross Margin | 69.72% | 69.30% | 0.6% | |
| Operating Margin | 28.25% | 28.37% | 0.4% | |
| Net Income Margin | 22.08% | 22.01% | 0.3% | |
| R&D Expenses | 646.10M | 748.10M | 15.8% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 7.04B | 6.18B | 5.37B | 4.83B | 4.85B |
| Gross Profit | 4.88B | 4.31B | 3.75B | 3.41B | 3.27B |
| Operating Income | 2.00B | 1.75B | 1.52B | 1.34B | 1.27B |
| Net Income | 1.55B | 1.36B | 1.19B | 1.10B | 949.70M |
| EPS | 14.4659 | 12.7983 | 11.2219 | 10.415 | 9.0794 |
| EBITDA | 3.04B | 2.66B | 2.12B | 1.88B | 1.78B |
| Gross Margin | 69.30% | 69.72% | 69.86% | 70.50% | 67.38% |
| Operating Margin | 28.37% | 28.25% | 28.38% | 27.63% | 26.24% |
| Net Income Margin | 22.01% | 22.08% | 22.12% | 22.69% | 19.56% |
| R&D Expenses | 748.10M | 646.10M | 529.80M | 484.80M | 423.60M |